Androgens influence expression of matrix proteins and proteolytic factors during cutaneous wound healing

Laboratory Investigation

Volumn 87, Issue 9, 2007, Pages 871-881

  Gilliver, Stephen C ^a   Ruckshanthi, Jayalath P D ^a   Atkinson, Susan J ^b   Ashcroft, Gillian S ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Castration; Collagen; Matrix metalloproteinases; Wound healing

Indexed keywords

ANDROGEN; COLLAGEN TYPE 1; COLLAGENASE 3; FIBRONECTIN; INTERSTITIAL COLLAGENASE; MATRIX PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CASTRATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; SKIN FIBROBLAST; SKIN INJURY; TURNOVER TIME; ULCER; WOUND HEALING;

AGING; ANDROGENS; ANIMALS; COLLAGEN TYPE I; COLLAGENASES; DISEASE MODELS, ANIMAL; FIBROBLASTS; FIBRONECTINS; MALE; MATRIX METALLOPROTEINASES; ORCHIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; WOUND HEALING;

EID: 34547931089     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700627     Document Type: Article

References (52)

1. Greiling D, Clark RA. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 1997;110:861-870.
2. Seppa H, Grotendorst G, Seppa S, et al. Platelet-derived growth factor is chemotactic for fibroblasts. J Cell Biol 1982;92:584-588.
3. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-4172.
4. Grinnell F, Billingham RE, Burgess L. Distribution of fibronectin during wound healing in vivo. J Invest Dermatol 1981;76:181-189.
5. Yeo TK, Brown L, Dvorak HF. Alterations in proteoglycan synthesis common to healing wounds and tumors. Am J Pathol 1991;138:1437-1450.
6. Betz P, Nerlich A, Wilske J, et al. Analysis of the immunohistochemical localization of collagen type III and V for the time-estimation of human skin wounds. Int J Legal Med 1993;105:329-332.
7. Bailey AJ, Bazin S, Sims TJ, et al. Characterization of the collagen of human hypertrophic and normal scars. Biochim Biophys Acta 1975;405:412-421.
8. Nagase H, Woessner Jr JF. Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494.
9. Toy LW. Matrix metalloproteinases: their function in tissue repair. J Wound Care 2005;14:20-22.
10. Inoue M, Kratz G, Haegerstrand A, et al. Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization. J Invest Dermatol 1995;104:479-483.
11. Rechardt O, Elomaa O, Vaalamo M, et al. Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines. J Invest Dermatol 2000;115:778-787.
12. Ashcroft GS, Herrick SE, Tarnuzzer RW, et al. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell Tissue Res 1997;290:581-591.
13. Shipley JM, Doyle GA, Fliszar CJ, et al. The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem 1996;271:4335-4341.
14. Watanabe K, Takahashi H, Habu Y, et al. Interaction with heparin and matrix metalloproteinase 2 cleavage expose a cryptic anti-adhesive site of fibronectin. Biochemistry 2000;39:7138-7144.
15. Zhao YG, Xiao AZ, Newcomer RG, et al. Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. J Biol Chem 2003;278:15056-15064.
16. Agren MS. Gelatinase activity during wound healing. Br J Dermatol 1994;131:634-640.
17. Chung L, Dinakarpandian D, Yoshida N, et al. Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. EMBO J 2004;23:3020-3030.
18. Ashcroft GS, Dodsworth J, van Boxtel E, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nat Med 1997;3:1209-1215.
19. Ashcroft GS, Mills SJ. Androgen receptor-mediated inhibition of cutaneous wound healing. J Clin Invest 2002;110:615-624.
20. Ashcroft GS, Horan MA, Ferguson MW. Aging is associated with reduced deposition of specific extracellular matrix components, an upregulation of angiogenesis, and an altered inflammatory response in a murine incisional wound healing model. J Invest Dermatol 1997;108:430-437.
21. Ashcroft GS, Kielty CM, Horan MA, et al. Age-related changes in the temporal and spatial distributions of fibrillin and elastin mRNAs and proteins in acute cutaneous wounds of healthy humans. J Pathol 1997;183:80-89.
22. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993;101:64-68.
23. Taylor RJ, Taylor AD, Smyth JV. Using an artificial neural network to predict healing times and risk factors for venous leg ulcers. J Wound Care 2002;11:101-105.
24. Ashcroft GS, Greenwell-Wild T, Horan MA, et al. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999;155:1137-1146.
25. Hembry RM, Murphy G, Cawston TE, et al. Characterization of a specific antiserum for mammalian collagenase from several species: immunolocalization of collagenase in rabbit chondrocytes and uterus. J Cell Sci 1986;81:105-123.
26. Knauper V, Will H, Lopez-Otin C, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996;271:17124-17131.
27. Junqueira LCU, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979;11:447-455.
28. Freshney RI. Culture of Animal Cells - A Manual of Basic Technique. Alan R Liss: New York, 1987.
29. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980;102:196-202.
30. Murphy G, Willenbrock F, Ward RV, et al. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J 1992;283:637-641.
31. Wu N, Jansen ED, Davidson J. Comparison of mouse matrix metalloproteinase 13 expression in free-electron laser and scalpel incisions during wound healing. J Invest Dermatol 2003;121:926-932.
32. Pirilä E, Korpi JT, Korkiamäki T, et al. Collagenase-2 (MMP-8) and matrilysin-2 (MMP-26) expression in human wounds of different etiologies. Wound Repair Regen 2007;15:47-57.
33. Tarlton JF, Bailey AJ, Crawford E, et al. Prognostic value of markers of collagen remodeling in venous ulcers. Wound Repair Regen 1999;7:347-355.
34. Weckroth M, Vaheri A, Lauharanta J, et al. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 1996;106:1119-1124.
35. Opas EE, Gentile MA, Rossert JA, et al. Parathyroid hormone and prostaglandin E2 preferentially increase luciferase levels in bone of mice harboring a luciferase transgene controlled by elements of the pro-α1(I) collagen promoter. Bone 2000;26:27-32.
36. Black MM, Shuster S, Bottoms E. Osteoporosis, skin collagen and androgen. Br Med J 1970;4:773-774.
37. Vaalamo M, Mattila L, Johansson N, et al. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol 1997;109:96-101.
38. Knäuper V, Cowell S, Smith B, et al. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997;272:7608-7616.
39. Seltzer JL, Eisen AZ, Bauer EA, et al. Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin. J Cell Biol 1989;264:3822-3826.
40. Murphy G, Cockett MI, Ward RV, et al. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J 1991;277:277-279.
41. Takashima A, Billingham RE, Grinnell F. Activation of rabbit keratinocyte fibronectin receptor function in vivo during wound healing. J Invest Dermatol 1986;86:585-590.
42. Lariviere B, Rouleau M, Picard S, et al. Human plasma fibronectin potentiates the mitogenic activity of platelet-derived growth factor and complements its wound healing effects. Wound Repair Regen 2003;11:79-89.
43. Kwon AH, Qiu Z, Hiraon Y. Effect of plasma fibronectin on the incisional wound healing in rats. Surgery 2007;141:254-261.
44. Herrick S, Ashcroft G, Ireland G, et al. Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation. Lab Invest 1997;77:281-288.
45. Pang ST, Flores-Morales A, Skoog L, et al. Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer. Oncol Rep 2004;11:1187-1192.
46. Schneikert J, Peterziel H, Defossez P-A, et al. Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression. J Biol Chem 1996;271:23907-23913.
47. Bolduc C, Larose M, Yoshioka M, et al. Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression. J Mol Endocrinol 2004;33:429-444.
48. Liao X, Thrasher JB, Pelling J, et al. Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology 2003;144:1656-1663.
49. Li BY, Liao XB, Fujito A, et al. Dual androgen-response elements mediate androgen regulation of MMP-2 expression in prostate cancer cells. Asian J Androl 2007;9:41-50.
50. Madlener M, Parks WC, Werner S. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 1998;242:201-210.
51. Will H, Atkinson SJ, Butler GS, et al. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 1996;271:17119-17123.
52. Atkinson SJ, Patterson ML, Butler MJ, et al. Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model. FEBS Lett 2001;491:222-226.